2002
DOI: 10.1034/j.1399-0004.2002.620403.x
|View full text |Cite
|
Sign up to set email alerts
|

Hair as a diagnostic tool in dysmorphology

Abstract: Clinical diagnosis in dysmorphology is made by the recognition of a specific pattern of malformations and through an analytic search for discrete features. We present our personal experience regarding the usefulness of hair morphology as a tool for diagnosis in some metabolic and malformation syndromes. These cases represent only a few illustrative examples; an exhaustive review of the topic can be found elsewhere.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 7 publications
(7 reference statements)
0
20
0
Order By: Relevance
“…In summary, our findings indicate that MPS types I, II, IIIA, and IIIB (but not MPS types IVA, IVB, and VI) can be considered as inherited metabolic diseases in which abnormalities in the hair occur, and that these abnormalities could provide a diagnostic tool, as in the case of some other genetic diseases [16,17]. Since we found previously, and confirmed in this report, that the morphology of hair changed over time and normalized during the enzyme replacement therapy of MPS I patients, one may suggest that the observation of changes in this parameter could be an additional method for assessing the efficacy of this and any other types of therapies tested or used in some types of MPS (types I, II, IIIA, and IIIB).…”
Section: Discussionmentioning
confidence: 89%
“…In summary, our findings indicate that MPS types I, II, IIIA, and IIIB (but not MPS types IVA, IVB, and VI) can be considered as inherited metabolic diseases in which abnormalities in the hair occur, and that these abnormalities could provide a diagnostic tool, as in the case of some other genetic diseases [16,17]. Since we found previously, and confirmed in this report, that the morphology of hair changed over time and normalized during the enzyme replacement therapy of MPS I patients, one may suggest that the observation of changes in this parameter could be an additional method for assessing the efficacy of this and any other types of therapies tested or used in some types of MPS (types I, II, IIIA, and IIIB).…”
Section: Discussionmentioning
confidence: 89%
“…The changes are similar to those present in other metabolic disorders like Menkes/occipital horn syndrome, biotinidase deficiency and argininosuccinic aciduria. In those diseases, hair anomalies are associated with specific metabolic defects that produce in turn defective cross-linking of the keratin (Menkes/occipital horn syndrome), biotin deprivation (biotinidase deficiency) and accumulation of toxic metabolites (argininosuccinic aciduria) [4]. We have recently observed similar hair changes in three patients affected by congenital disorders of glycosylation [5].…”
Section: Discussionmentioning
confidence: 96%
“…Body hair is often diminished or absent. Eyebrows and eyelashes may be lacking [Silengo et al, 2002]. Decreased tear production, cataracts, and strabismus may occur.…”
Section: Clinical Features Of Various Ectodermal Dysplasiasmentioning
confidence: 97%